SCHEMBL4896172

SCHEMBL4896172

COCCC(C)C(=Cc1ccc(OC)cc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
THRB P10828 1/20 0.42
ATM Q13315 1/20 0.42
ALDH1A1 P00352 4/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
POLB P06746 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
AKR1C3 P42330 1/20 0.41
GSK3B P49841 1/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906426 0.81 THRB (0.50) THRBATMALDH1A1CYP1A2CYP3A4
SCHEMBL4879128 0.81 THRB (0.50) THRBATMALDH1A1CYP1A2CYP3A4
SCHEMBL490213 0.81 THRB (0.50) THRBATMALDH1A1CYP1A2CYP3A4
SCHEMBL8153615 0.78 CYP1A2 (0.52) THRBATMALDH1A1CYP1A2CYP3A4
SCHEMBL16266991 0.76 THRB (0.49) THRBATMALDH1A1CYP1A2CYP3A4
SCHEMBL5085450 0.76 THRB (0.43) LMNATDP1THRBATMALDH1A1
SCHEMBL4896183 0.75 THRB (0.45) THRBATMALDH1A1CYP1A2CYP3A4
SCHEMBL4896165 0.75 THRB (0.45) THRBATMALDH1A1CYP1A2CYP3A4
SCHEMBL7820837 0.73 THRB (0.56) THRBATMALDH1A1CYP1A2CYP3A4
SCHEMBL7820839 0.73 THRB (0.56) THRBATMALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242876-A1 Process For the Manufacture of Substituted Propionic Acids PHOENIX CHEMICALS LTD. (GB) 2008-10-02 US disclosed
EP-1838654-A1 PROCESS FOR THE MANUFACTURE OF SUBSTITUTED PROPIONIC ACIDS Phoenix Chemicals Limited (GB) 2007-10-03 EP disclosed
WO-2006075177-A1 PROCESS FOR THE MANUFACTURE OF SUBSTITUTED PROPIONIC ACIDS PHOENIX CHEMICALS LTD. (GB) 2006-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242876-A1 Process For the Manufacture of Substituted Propionic Acids AS3MT, PPA1, AGPS LMNA 4265/4885TDP1 4566/4885THRB 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.